FMP
Shattuck Labs, Inc.
STTK
NASDAQ
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
9.78 USD
-0.12 (-1.23%)
About
ceo
Ms. Casi DeYoung
sector
Healthcare
industry
Biotechnology
website
https://www.shattucklabs.com
exchange
NASDAQ
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.
CIK
0001680367
ISIN
US82024L1035
CUSIP
82024L103
Address
500 West 5th Street
Phone
512 900 4690
Country
US
Employee
75
IPO Date
Oct 9, 2020
Summary
CIK
0001680367
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
82024L103
ISIN
US82024L1035
Country
US
Price
9.78
Beta
2.13
Volume Avg.
329.38k
Market Cap
464.3M
Shares
-
52-Week
1.33-11.11
DCF
1.84
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-4.77
P/B
-
Website
https://www.shattucklabs.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest STTK News
It looks like there's no news available.
